The rise of Viagra initially fueled a boom for pharma, however recent developments present a uncertain scenario for shareholders. Off-patent alternatives are eroding earnings, and persistent legal battles add more https://lewisqsjq616872.blogocial.com/sildenafil-and-big-pharma-a-volatile-bet-77206229